Literature DB >> 21520456

Assessing noninferiority in a three-arm trial using the Bayesian approach.

Pulak Ghosh1, Farouk Nathoo, Mithat Gönen, Ram C Tiwari.   

Abstract

Non-inferiority trials, which aim to demonstrate that a test product is not worse than a competitor by more than a pre-specified small amount, are of great importance to the pharmaceutical community. As a result, methodology for designing and analyzing such trials is required, and developing new methods for such analysis is an important area of statistical research. The three-arm trial consists of a placebo, a reference and an experimental treatment, and simultaneously tests the superiority of the reference over the placebo along with comparing this reference to an experimental treatment. In this paper, we consider the analysis of non-inferiority trials using Bayesian methods which incorporate both parametric as well as semi-parametric models. The resulting testing approach is both flexible and robust. The benefit of the proposed Bayesian methods is assessed via simulation, based on a study examining home-based blood pressure interventions.
Copyright © 2011 John Wiley & Sons, Ltd.

Mesh:

Substances:

Year:  2011        PMID: 21520456     DOI: 10.1002/sim.4244

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  6 in total

1.  Bayesian Approach for Assessing Non-inferiority in Three-arm Trials for Risk Ratio and Odds Ratio.

Authors:  Shrabanti Chowdhury; Ram C Tiwari; Samiran Ghosh
Journal:  Stat Biopharm Res       Date:  2019-04-22       Impact factor: 1.452

2.  Improving clinical trial interpretation with ACCEPT analyses.

Authors:  Michelle N Clements; Ian R White; Andrew J Copas; Victoria Cornelius; Suzie Cro; David T Dunn; Matteo Quartagno; Rebecca M Turner; Conor D Tweed; A Sarah Walker
Journal:  NEJM Evid       Date:  2022-07-26

3.  Confidence limits for the averted infections ratio estimated via the counterfactual placebo incidence rate.

Authors:  David T Dunn; Oliver T Stirrup; David V Glidden
Journal:  Stat Commun Infect Dis       Date:  2021-11-24

Review 4.  The averted infections ratio: a novel measure of effectiveness of experimental HIV pre-exposure prophylaxis agents.

Authors:  David T Dunn; David V Glidden; Oliver T Stirrup; Sheena McCormack
Journal:  Lancet HIV       Date:  2018-06       Impact factor: 12.767

5.  New approaches for testing non-inferiority for three-arm trials with Poisson distributed outcomes.

Authors:  Samiran Ghosh; Erina Paul; Shrabanti Chowdhury; Ram C Tiwari
Journal:  Biostatistics       Date:  2022-01-13       Impact factor: 5.899

6.  Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints.

Authors:  Nian-Sheng Tang; Bin Yu; Man-Lai Tang
Journal:  BMC Med Res Methodol       Date:  2014-12-18       Impact factor: 4.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.